Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
CONCLUSION: Statins can prevent the proliferative HCB effects on Hep-G2 cells. TGF-β1, c-Src and TH may be the statins molecular targets in hepatocarcinogenesis.
PMID: 29735800 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Atorvastatin Calcium | Cancer & Oncology | Carcinoma | Cholesterol | Hepatocellular Carcinoma | Hormones | Lipitor | Liver | Liver Cancer | Nutrition | Simvastatin | Statin Therapy | Study | Thyroid | Thyroid Cancer | Urology & Nephrology | Zivast | Zocor